Evidence map›Paper›PMID 36033159›Full record

ReviewCurrent opinion in biomedical engineering2022

Recent advances in copper and copper-derived materials for antimicrobial resistance and infection control.

Neha Bisht, Neeraj Dwivedi, Pradip Kumar, Mayandi Venkatesh, Amit K Yadav, Deepti Mishra, Pratima Solanki, Navin Kumar Verma, Rajamani Lakshminarayanan, Seeram Ramakrishna and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in biomedical engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A broad-spectrum inhibitor of copper-exporting PProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. A First-In-Class Broad Spectrum Inhibitor of Copper Exporting PbioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Antimicrobial Efficacy of Copper Complexes: A Review.Antibiotics (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Neha BishtCSIR-Advanced Materials and Processes Research Institute (CSIR-AMPRI), Bhopal 462026, MP, India.
Neeraj DwivediCSIR-Advanced Materials and Processes Research Institute (CSIR-AMPRI), Bhopal 462026, MP, India.
Pradip KumarCSIR-Advanced Materials and Processes Research Institute (CSIR-AMPRI), Bhopal 462026, MP, India.
Mayandi VenkateshOcular Infections & Anti-Infectives Research Group, Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, 169856, Singapore.
Amit K YadavSpecial Centre for Nanoscience, Jawaharlal Nehru University, New Delhi 110067, India.
Deepti MishraCSIR-Advanced Materials and Processes Research Institute (CSIR-AMPRI), Bhopal 462026, MP, India.
Pratima SolankiSpecial Centre for Nanoscience, Jawaharlal Nehru University, New Delhi 110067, India.
Navin Kumar VermaLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Clinical Sciences Building, 11 Mandalay Road, 308232, Singapore.
Rajamani LakshminarayananOcular Infections & Anti-Infectives Research Group, Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, 169856, Singapore.
Seeram RamakrishnaCenter for Nanofibers and Nanotechnology, Department of Mechanical Engineering, Faculty of Engineering, 2 Engineering Drive 3, National University of Singapore, 117576, Singapore.
D P MondalCSIR-Advanced Materials and Processes Research Institute (CSIR-AMPRI), Bhopal 462026, MP, India.
Avanish Kumar SrivastavaCSIR-Advanced Materials and Processes Research Institute (CSIR-AMPRI), Bhopal 462026, MP, India.
Chetna DhandCSIR-Advanced Materials and Processes Research Institute (CSIR-AMPRI), Bhopal 462026, MP, India.
Advanced Materials and Processes Research Institute · INJawaharlal Nehru University · INSingapore Eye Research Institute · SGNational Skin Centre · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibacterial properties of copper have been known for ages. With the rise of antimicrobial resistance (AMR), hospital-acquired infections, and the current SARS-CoV-2 pandemic, copper and copper-derived materials are being widely researched for healthcare ranging from therapeutics to advanced wound dressing to medical devices. We cover current research that highlights the potential uses of metallic and ionic copper, copper alloys, copper nanostructures, and copper composites as antibacterial, antifungal, and antiviral agents, including those against the SARS-CoV-2 virus. The applications of copper-enabled engineered materials in medical devices, wound dressings, personal protective equipment, and self-cleaning surfaces are discussed. We emphasize the potential of copper and copper-derived materials in combating AMR and efficiently reducing infections in clinical settings.

Indexed as

Antimicrobial agentsCopperEffectiveness against COVID-19HealthcareWound dressings

Identifiers

PMID36033159
PMCPMC9395285
OpenAlexW4292833037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.